CervoMed Inc.
CervoMed Inc. (CRVO): 1 pipeline candidate · ~5 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
5.0 months
D/E 0.42 · 0% dilution
Lead: Phase 2
1 candidate
N/A
N/A
A transparent, data-derived signal for CervoMed Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$23.0M
Cash
$7.9M
Quarterly Burn
$8.0M
Runway
5.0 mo
Revenue
$0
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| neflamapimod | Phase 2 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
36
Total value held
$8.2M
| Holder | Shares | Value |
|---|---|---|
| morgan stanley | 739,892 | $2.9M |
| vanguard capital management llc | 632,404 | $2.5M |
| millennium management llc | 208,908 | $823K |
| geode capital management, llc | 74,371 | $293K |
| renaissance technologies llc | 63,904 | $252K |
| blackrock, inc. | 51,660 | $204K |
| xtx topco ltd | 38,487 | $152K |
| citizens financial group inc/ri | 37,477 | $148K |
| vanguard fiduciary trust co | 36,151 | $142K |
| northern trust corp | 30,044 | $118K |
Showing top 10 of 36 institutional holders of CervoMed Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in CervoMed Inc.'s pipeline?
CervoMed Inc. (CRVO) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.
What is CervoMed Inc.'s lead drug candidate?
CervoMed Inc.'s most advanced tracked candidate is neflamapimod (Phase 2) for dementia with Lewy bodies (DLB).
What is CervoMed Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, CervoMed Inc. has approximately 5.0 months of cash runway.
What is CervoMed Inc.'s market capitalization?
CervoMed Inc.'s market capitalization is approximately $23.0M.
Who is the CEO of CervoMed Inc.?
Dr. John J. Alam M.D. is the chief executive officer of CervoMed Inc. (CRVO).
Get the full picture on CervoMed Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.